Llido, Ailyn M.

HRN: 21-52-02  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/02/2022
CEFUROXIME 750MG (VIAL)
07/02/2022
07/08/2022
IV
759ng
Q8 Hours
S/P LTCS
07/03/2022
CEFUROXIME 500MG (TAB)
07/03/2022
07/10/2022
PO
500mg
Q12H
S/p LTCS
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: